MoonLake Immunotherapeutics Data Shows Phase 2 Success For Chronic Back Pain

Axial Spondyloarthritis is a chronic, immune-mediated inflammatory disease mainly affecting the spine and sacroiliac joints, often causing chronic back pain, stiffness, and potential spinal fusion.Chronic Back Pain StudyIn the Phase 2 S-OLARIS trial, 81% of patients treated with sonelokimab achieved a clinically meaningful response at Week 12, demonstrating significant improvement in key disease parameters.The trial also confirmed the drug’s ability to reduce inflammation and osteoblast activity in affected ...